欧洲血管外科学会2023版《动脉粥样硬化性颈动脉和椎动脉疾病管理的临床实践指南》解读  

Interpretation of the European Society for Vascular Surgery(ESVS)2023 Clinical Practice Guidelines on the Management of Atherosclerotic Carotid and Vertebral Artery Disease

作　　者：马博[1] 叶志东[1] 刘鹏[1] MA Bo;YE Zhidong;LIU Peng(Department of Cardiovascular Surgery,China-Japan Friendship Hospital,Beijing 100029,China)

机构地区：[1]中日友好医院心脏血管外科,北京100029

出　　处：《中国普通外科杂志》2023年第12期1829-1841,共13页China Journal of General Surgery

摘　　要：欧洲血管外科学会(ESVS)发布了2023版《动脉粥样硬化性颈动脉和椎动脉疾病管理的临床实践指南》,对颈动脉和椎动脉病变的诊疗策略进行了全面而详细的介绍。该指南一共包含了133条推荐,其中11条推荐更新了证据等级或推荐强度,38条为新发布的推荐。动脉粥样硬化性颈动脉和椎动脉狭窄是缺血性卒中的重要病因,合理的管理治疗策略能够降低卒中风险。因此,笔者根据指南的循证医学证据,结合我国临床实际,对指南内容进行解读,以期帮助临床医务人员更好地管理动脉粥样硬化性颈动脉和椎动脉患者。The European Society for Vascular Surgery(ESVS)has released the 2023 edition of"Clinical Practice Guidelines on the Management of Atherosclerotic Carotid and Vertebral Artery Disease",providing a comprehensive and detailed descriptions of diagnostic and therapeutic strategies for carotid and vertebral artery disorders.The guidelines consist of a total of 133 recommendations,among which 11 recommendations have been revised in terms of evidence grades or recommendation strengths,and 38 are newly introduced recommendations.Atherosclerotic carotid and vertebral artery stenosis are critical contributors to ischemic stroke,and a rational management and treatment strategies can reduce the risk of stroke.Therefore,the authors,based on the information from evidence-based medicine in the guidelines and considering the clinical practices in our country,interpret the content of the guidelines with the aim of assisting healthcare professionals in better managing patients with atherosclerotic carotid and vertebral artery diseases.

关 键 词：动脉粥样硬化 颈动脉 椎动脉 诊疗指南 

分 类 号：R654.3[医药卫生—外科学]